Evidence map›Paper›PMID 33960714›Full record

ArticleBrain and behavior2021

The Delta Study - Prevalence and characteristics of mood disorders in 924 individuals with low mood: Results of the of the World Health Organization Composite International Diagnostic Interview (CIDI).

Nayra A Martin-Key, Tony Olmert, Giles Barton-Owen, Sung Yeon Sarah Han, Jason D Cooper, Pawel Eljasz, Lynn P Farrag, Lauren V Friend, Emily Bell, Dan Cowell and 2 more

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Nayra A Martin-KeyDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID 0000-0002-9731-3809
Tony OlmertDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID 0000-0003-4641-6442
Giles Barton-OwenPsyomics Ltd, Cambridge, UK.
Sung Yeon Sarah HanDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Jason D CooperDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Pawel EljaszDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Lynn P FarragPsyomics Ltd, Cambridge, UK.
Lauren V FriendPsyomics Ltd, Cambridge, UK.
Emily BellPsyomics Ltd, Cambridge, UK.
Dan CowellPsyomics Ltd, Cambridge, UK.
Jakub TomasikDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID 0000-0002-2127-4487
Sabine BahnDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
University of Cambridge · GBAlcyomics (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe Delta Study was undertaken to improve the diagnosis of mood disorders in individuals presenting with low mood. The current study aimed to estimate the prevalence and explore the characteristics of mood disorders in participants of the Delta Study, and discuss their implications for clinical practice.

methodsIndividuals with low mood (Patients Health Questionnaire-9 score ≥5) and either no previous mood disorder diagnosis (baseline low mood group, n = 429), a recent (≤5 years) clinical diagnosis of MDD (baseline MDD group, n = 441) or a previous clinical diagnosis of BD (established BD group, n = 54), were recruited online. Self-reported demographic and clinical data were collected through an extensive online mental health questionnaire and mood disorder diagnoses were determined with the World Health Organization Composite International Diagnostic Interview (CIDI).

resultsThe prevalence of BD and MDD in the baseline low mood group was 24% and 36%, respectively. The prevalence of BD among individuals with a recent diagnosis of MDD was 31%. Participants with BD in both baseline low mood and baseline MDD groups were characterized by a younger age at onset of the first low mood episode, more severe depressive symptoms and lower wellbeing, relative to the MDD or low mood groups. Approximately half the individuals with BD diagnosed as MDD (49%) had experienced (hypo)manic symptoms prior to being diagnosed with MDD.

conclusionsThe current results confirm high under- and misdiagnosis rates of mood disorders in individuals presenting with low mood, potentially leading to worsening of symptoms and decreased well-being, and indicate the need for improved mental health triage in primary care.

Indexed as

Bipolar DisorderMajor Depressive DisorderDepressionHumansMood DisordersPrevalenceWorld Health Organizationbipolar disorderdiagnostic errorsmajor depressive disordermood disordersprevalence

Identifiers

PMID33960714
PMCPMC8213940
OpenAlexW3158149152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.